Cancellation · USPTO

Cancellation 92062969

OtherUSPTO

Cancellation 92062969 at USPTO between NeoGenomics Laboratories, Inc. and Neogenix Oncology, Inc., over the mark NEOGENIX ONCOLOGY, filed Jan 15, 2016. Status in the office record: other.

Status
Other
Result
Other
Filed
Jan 15, 2016
Marks involved
10
Parties

Who is involved

The parties as named in the office record.

Petitioner

NeoGenomics Laboratories, Inc.

Company trademarks
Respondent

Neogenix Oncology, Inc.

Timeline

How the case has moved

Dates from the USPTO record and the NEOGENIX ONCOLOGY filing.

  1. NEOGENIX ONCOLOGY filed

    Application 77795852 filed at the USPTO.
  2. NEOGENIX ONCOLOGY registered

  3. Cancellation filed

    NeoGenomics Laboratories, Inc. started cancellation 92062969 at USPTO against NEOGENIX ONCOLOGY.
Marks

Marks involved

2 contested marks, 8 marks the challenger relies on.

MarkRoleApplicationOffice
NEOGENIX ONCOLOGYContested77795852USPTO
NEOGENIXContested85141815USPTO
NEOGENOMICSRelied on78947056USPTO
NEOFISHRelied on85323988USPTO
NEOFLOWRelied on85324005USPTO
NEOTYPERelied on85685014USPTO
NEOARRAYRelied on85767118USPTO
NEOSITERelied on85800853USPTO
NEOPATHRelied on86000484USPTO
NEOGENOMICS LABORATORIESRelied on86315917USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

GET /v1/proceedings/{id}
ID=prc_76eb7d27-098f-46e6-b6ff-ec12c918ad09
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_76eb7d27-098f-46e6-b6ff-ec12c918ad09",
  "object": "proceeding",
  "proceeding_type": "cancellation",
  "proceeding_number": "92062969",
  "status": "other",
  "office_code": "US",
  "filed_date": "2016-01-15",
  "parties": [
    {
      "name": "NeoGenomics Laboratories, Inc.",
      "role": "petitioner"
    },
    {
      "name": "Neogenix Oncology, Inc.",
      "role": "respondent"
    }
  ]
}